Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Nuvasive Inc (NUVA)

Nuvasive Inc (NUVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,084,848
  • Shares Outstanding, K 52,449
  • Annual Sales, $ 1,202 M
  • Annual Income, $ 40,410 K
  • 60-Month Beta 1.07
  • Price/Sales 1.77
  • Price/Cash Flow 8.01
  • Price/Book 2.34
Trade NUVA with:
  • Price/Earnings ttm 20.33
  • Earnings Per Share ttm 2.00
  • Most Recent Earnings $0.56 on 08/02/23
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/23
See More
  • Average Estimate 0.54
  • Number of Estimates 7
  • High Estimate 0.76
  • Low Estimate 0.48
  • Prior Year 0.54
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
37.93 +4.80%
on 08/25/23
41.73 -4.74%
on 08/01/23
-1.46 (-3.54%)
since 07/31/23
3-Month
37.90 +4.88%
on 06/01/23
44.12 -9.90%
on 07/19/23
+1.59 (+4.17%)
since 05/31/23
52-Week
35.17 +13.02%
on 11/17/22
49.53 -19.75%
on 02/09/23
-3.83 (-8.79%)
since 08/26/22

Most Recent Stories

More News
NuVasive to Participate as Double Diamond Sponsor at Scoliosis Research Society Annual Meeting

/PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive,...

NUVA : 39.75 (-2.24%)
NuVasive: Q2 Earnings Snapshot

NuVasive: Q2 Earnings Snapshot

NUVA : 39.75 (-2.24%)
NuVasive Announces Second Quarter 2023 Financial Results

/PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive,...

NUVA : 39.75 (-2.24%)
NuVasive Announces Conference Call and Webcast of Second Quarter 2023 Results

/PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive,...

NUVA : 39.75 (-2.24%)
NuVasive (NUVA) Tops Q1 Earnings and Revenue Estimates

NuVasive (NUVA) delivered earnings and revenue surprises of 14.63% and 3.11%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

NUVA : 39.75 (-2.24%)
EYE : 14.17 (+0.50%)
NuVasive: Q1 Earnings Snapshot

NuVasive: Q1 Earnings Snapshot

NUVA : 39.75 (-2.24%)
NuVasive Announces First Quarter 2023 Financial Results

/PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive,...

NUVA : 39.75 (-2.24%)
AdaptHealth Corp. (AHCO) Q1 Earnings and Revenues Lag Estimates

AdaptHealth Corp. (AHCO) delivered earnings and revenue surprises of -87.50% and 2.03%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

AHCO : 9.99 (-1.19%)
NUVA : 39.75 (-2.24%)
NuVasive Announces Conference Call and Webcast of First Quarter 2023 Results

/PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive,...

NUVA : 39.75 (-2.24%)
Is NuVasive (NUVA) a Great Value Stock Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest...

NUVA : 39.75 (-2.24%)
PHG : 27.24 (-0.55%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

NuVasive, Inc. is one of the leading global medical device companies in the global spine market, focused on developing minimally-disruptive surgical products and procedurally-integrated solutions for the spine. The principal product offering includes a minimally-disruptive surgical platform called Maximum...

See More

Key Turning Points

3rd Resistance Point 42.15
2nd Resistance Point 41.58
1st Resistance Point 40.66
Last Price 39.75
1st Support Level 39.17
2nd Support Level 38.60
3rd Support Level 37.68

See More

52-Week High 49.53
Fibonacci 61.8% 44.04
Fibonacci 50% 42.35
Fibonacci 38.2% 40.66
Last Price 39.75
52-Week Low 35.17

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar